300 Longwood Avenue Boston, MA 02115 (617) 355-6000 Research: Bruce Zetter remembers Judah Folkman Bruce Zetter, PhD, Children's Hospital Boston's chief scientific officer, joined Judah Folkman's laboratory in 1978. The following year he and Dr. Folkman showed that endothelial cells in large blood vessels are different from those in capillaries, a milestone in angiogenesis research. In 1980 Dr. Zetter went on to identify the first angiogenesis inhibitor, interferon-alpha. Video Clips You joined Dr. Folkman's lab at a time when his ideas were not always well regarded by other scientists. What was it like working with him in those early days? What has it been like for you and other staff during the years since? [06:18; 12.5 MB] View clip... What effect did Dr. Folkman had on the research of cancer and other diseases? [03:45; 7.5 MB] View clip... Should Dr. Folkman have received the Nobel Prize? [02:55; 5.8 MB] View clip... Do you have any anecdotes that you'd like to share? [02:32; 5.1 MB] View clip... [Note: The free QuickTime player is required to view these video clips. If you can hear the audio but see no picture, you may need to install a more recent version of QuickTime.] For more memories, visit our Judah Folkman tribute site. The information on this website should not be taken as medical advice, which can only be given to you by your personal health care professional. Copyright © Children's Hospital Boston. All rights reserved.